TIMBLIZ
Live / Allowed — Notice of allowance issued (as of 04 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 17 Oct 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99448697
- Mark type
- Word mark
- Filed
- 17 Oct 2025
- Published for opposition
- 09 Jun 2026
- Attorney of record
- Christopher D Olszyk, Jr.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical beta-blocker preparations; Pharmaceutical beta-blocker preparations in the form of a topical gel; Ophthalmic preparations containing timolol; Pharmaceutical preparations for the treatment of high blood pressure, glaucoma, and migraines; Pharmaceutical preparations for the treatment of elevated intraocular pressure in ocular hypertension or open angle glaucoma; Pharmaceutical preparations for the treatment of skin conditions, namely, infantile hemangiomas and chronic venous leg ulcers; Medicated cosmetics
Owner
- Auson Pharmaceuticals Inc., Bridgewater, NJ, US
- Auson Pharmaceuticals Inc., Bridgewater, NJ, US
Prosecution history
- 04 Aug 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Jun 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Jun 2026 — PUBLISHED FOR OPPOSITION
- 03 Jun 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 May 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 May 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 May 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 May 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 05 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 05 Mar 2026 — NON-FINAL ACTION E-MAILED
- 05 Mar 2026 — NON-FINAL ACTION WRITTEN
- 05 Mar 2026 — ASSIGNED TO EXAMINER
- 03 Mar 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 17 Oct 2025 — APPLICATION FILING RECEIPT MAILED
- 17 Oct 2025 — NEW APPLICATION ENTERED